Fermenta Biotech Limited Q4 FY25 results press release summary

Results press release of 28 May 2025, summarised by AI from the filing.

Fermenta FY25 consolidated revenue ₹481.3 cr, up 39% YoY, with PAT ₹76.4 cr vs year-ago loss.

Key takeaways

1. FY25 results Consolidated revenue ₹481.3 cr (up 39% YoY) and PAT ₹76.4 cr vs year-ago loss.
2. Guidance No forward guidance was provided in the release.
3. Driver Vitamin D3 Human Nutrition revenue ₹216.3 cr (+54%) and Animal Nutrition ₹94.0 cr (+146%).
4. Risk No specific risks were acknowledged in the release.

Original filing on BSE

Fermenta Biotech Limited Q1 FY27 results

As filed: Revenue ₹112 cr, EBITDA ₹23.0 cr, PAT ₹15.0 cr, EBITDA margin 20.6%.

Not scored. No result for the same quarter last year.

Fermenta Biotech Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (11 Aug 2026), Results press release (11 Aug 2026)
• Q4 FY26: Results deck (26 May 2026), Results press release (26 May 2026)
• Q3 FY26: Results deck (11 Feb 2026), Results press release (9 Feb 2026)
• Q2 FY26: Results deck (12 Nov 2025), Results press release (11 Nov 2025)
• Q1 FY26: Results deck (13 Aug 2025)
• Q4 FY25: Results deck (4 Jun 2025), Results press release (28 May 2025)